NKLA Nikola | $1.22
-9.3% | 11/7/2024 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | N/A | View details for Bryan, Garnier & Co rating of Nikola (NASDAQ:NKLA) on 11/7/2024 |
NKLA Nikola | $1.22
-9.3% | 5/16/2024 | Initiated by | Bryan, Garnier & Co | - | Buy | $30.00 | Low | View details for Bryan, Garnier & Co rating of Nikola (NASDAQ:NKLA) on 5/16/2024 |
MLTX MoonLake Immunotherapeutics | $45.82
+4.6% | 9/14/2023 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 9/14/2023 |
TVTX Travere Therapeutics | $19.46
+5.9% | 5/5/2023 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 5/5/2023 |
IMCR Immunocore | $30.00
+3.4% | 3/24/2023 | Initiated by | Bryan, Garnier & Co | - | Buy | $16.00 | Low | View details for Bryan, Garnier & Co rating of Immunocore (NASDAQ:IMCR) on 3/24/2023 |
IMTX Immatics | $5.40
+0.9% | 3/24/2023 | Initiated by | Bryan, Garnier & Co | - | Buy | $16.00 | Low | View details for Bryan, Garnier & Co rating of Immatics (NASDAQ:IMTX) on 3/24/2023 |
ADAP Adaptimmune Therapeutics | $0.57
-1.7% | 3/24/2023 | Initiated by | Bryan, Garnier & Co | - | Buy | $3.60 | Low | View details for Bryan, Garnier & Co rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 3/24/2023 |
CRSP CRISPR Therapeutics | $41.51
+2.4% | 3/17/2023 | Initiated by | Bryan, Garnier & Co | - | Buy | $70.00 | Low | View details for Bryan, Garnier & Co rating of CRISPR Therapeutics (NASDAQ:CRSP) on 3/17/2023 |
CLLS Cellectis | $1.51
+2.0% | 3/17/2023 | Initiated by | Bryan, Garnier & Co | - | Buy | $6.00 | Low | View details for Bryan, Garnier & Co rating of Cellectis (NASDAQ:CLLS) on 3/17/2023 |
AUTL Autolus Therapeutics | $2.19
-1.4% | 3/17/2023 | Initiated by | Bryan, Garnier & Co | - | Buy | $5.00 | Low | View details for Bryan, Garnier & Co rating of Autolus Therapeutics (NASDAQ:AUTL) on 3/17/2023 |
|
MLTX MoonLake Immunotherapeutics | $45.82
+4.6% | 2/2/2023 | Initiated by | Bryan, Garnier & Co | - | Buy | $22.00 | Low | View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 2/2/2023 |
SAP SAP | €256.75
+0.3% | 12/14/2022 | Target Set by | Bryan, Garnier & Co | Analyst Gregory Ramirez | | €130.00 | N/A | View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 12/14/2022 |
CRRFY Carrefour | $2.81
+2.9% | 11/16/2022 | Downgraded by | Bryan, Garnier & Co | Analyst Clement Genelot | Buy -> Neutral | $22.00 -> $20.00 | Low | View details for Bryan, Garnier & Co rating of Carrefour (OTCMKTS:CRRFY) on 11/16/2022 |
TMSNY Temenos | $80.60
+1.4% | 10/17/2022 | Downgraded by | Bryan, Garnier & Co | Analyst Gregory Ramirez | Buy -> Neutral | $118.00 -> $58.00 | Low | View details for Bryan, Garnier & Co rating of Temenos (OTCMKTS:TMSNY) on 10/17/2022 |
PHVS Pharvaris | $19.12
+4.1% | 10/5/2022 | Initiated by | Bryan, Garnier & Co | - | Buy | $16.00 | Low | View details for Bryan, Garnier & Co rating of Pharvaris (NASDAQ:PHVS) on 10/5/2022 |
TVTX Travere Therapeutics | $19.46
+5.9% | 9/21/2022 | Initiated by | Bryan, Garnier & Co | - | Sell | $17.00 | Low | View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 9/21/2022 |
SGBAF SES | $3.16
+7.3% | 9/20/2022 | Initiated by | Bryan, Garnier & Co | Analyst Thomas Coudry | Neutral | $6.50 | Low | View details for Bryan, Garnier & Co rating of SES (OTCMKTS:SGBAF) on 9/20/2022 |
TAP Molson Coors Beverage | $55.72
+0.9% | 9/1/2022 | Downgraded by | Bryan, Garnier & Co | Analyst Nikolaas Faes | Buy -> Sell | $54.00 | Low | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 9/1/2022 |
ADRNY Koninklijke Ahold Delhaize | €35.79
+2.6% | 8/31/2022 | Upgraded by | Bryan, Garnier & Co | Analyst Clement Genelot | Neutral -> Buy | €31.00 -> €34.00 | Low | View details for Bryan, Garnier & Co rating of Koninklijke Ahold Delhaize (OTCMKTS:ADRNY) on 8/31/2022 |
ADYEY Adyen | $15.60
+2.0% | 8/19/2022 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Adyen (OTCMKTS:ADYEY) on 8/19/2022 |
CMPGY Compass Group | $33.39
+2.6% | 6/9/2022 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Medium | View details for Bryan, Garnier & Co rating of Compass Group (OTCMKTS:CMPGY) on 6/9/2022 |
ZLNDY Zalando | $16.37
-0.1% | 6/1/2022 | Downgraded by | Bryan, Garnier & Co | Analyst Clement Genelot | Neutral -> Sell | $87.00 -> $38.00 | High | View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 6/1/2022 |
GMAB Genmab A/S | $21.80
+4.8% | 5/13/2022 | Upgraded by | Bryan, Garnier & Co | Analyst Victor Floch | Sell -> Neutral | | Medium | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 5/13/2022 |
NVO Novo Nordisk A/S | $80.95
+2.9% | 5/5/2022 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 5/5/2022 |
BLDR Builders FirstSource | $166.28
+1.3% | 4/6/2022 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | $71.00 | High | View details for Bryan, Garnier & Co rating of Builders FirstSource (NYSE:BLDR) on 4/6/2022 |
HNNMY H & M Hennes & Mauritz AB (publ) | $2.65
-0.4% | 4/4/2022 | Downgraded by | Bryan, Garnier & Co | Analyst Cedric Rossi | Buy -> Neutral | $225.00 -> $190.00 | Low | View details for Bryan, Garnier & Co rating of H & M Hennes & Mauritz AB (publ) (OTCMKTS:HNNMY) on 4/4/2022 |
SDXAY Sodexo | $14.58
+2.1% | 3/25/2022 | Downgraded by | Bryan, Garnier & Co | Analyst Bruno De La Rochebrochard | Strong-Buy -> Buy | $95.00 | Low | View details for Bryan, Garnier & Co rating of Sodexo (OTCMKTS:SDXAY) on 3/25/2022 |
MTLS Materialise | $7.87
+3.6% | 3/25/2022 | Downgraded by | Bryan, Garnier & Co | Analyst Gregory Ramirez | Buy -> Neutral | $20.00 | Low | View details for Bryan, Garnier & Co rating of Materialise (NASDAQ:MTLS) on 3/25/2022 |
DASTY Dassault Systèmes | $36.80
+2.8% | 3/25/2022 | Downgraded by | Bryan, Garnier & Co | Analyst Gregory Ramirez | Buy -> Neutral | $49.00 | High | View details for Bryan, Garnier & Co rating of Dassault Systèmes (OTCMKTS:DASTY) on 3/25/2022 |
HESAY Hermès International Société en commandite par actions | $267.83
+4.1% | 3/18/2022 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Low | View details for Bryan, Garnier & Co rating of Hermès International Société en commandite par actions (OTCMKTS:HESAY) on 3/18/2022 |
TIIAY Telecom Italia | $2.64
-0.3% | 3/14/2022 | Upgraded by | Bryan, Garnier & Co | Analyst Thomas Coudry | Neutral -> Buy | | Medium | View details for Bryan, Garnier & Co rating of Telecom Italia (OTCMKTS:TIIAY) on 3/14/2022 |
ZLNDY Zalando | $16.37
-0.1% | 3/4/2022 | Downgraded by | Bryan, Garnier & Co | - | Neutral | | High | View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 3/4/2022 |
GLPG Galapagos | $23.83
+0.3% | 1/28/2022 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Buy | | High | View details for Bryan, Garnier & Co rating of Galapagos (NASDAQ:GLPG) on 1/28/2022 |
NVS Novartis | $99.69
+2.2% | 12/3/2021 | Reiterated by | Bryan, Garnier & Co | Analyst Jeanjacques Le | Buy -> Neutral | $115.00 -> $85.00 | Low | View details for Bryan, Garnier & Co rating of Novartis (NYSE:NVS) on 12/3/2021 |
AZN AstraZeneca | $67.96
+2.0% | 11/22/2021 | Downgraded by | Bryan, Garnier & Co | - | Buy | | Low | View details for Bryan, Garnier & Co rating of AstraZeneca (NASDAQ:AZN) on 11/22/2021 |
NVO Novo Nordisk A/S | $80.95
+2.9% | 11/3/2021 | Downgraded by | Bryan, Garnier & Co | Analyst Jean-Jacques Le | Buy -> Sell | $148.00 | High | View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 11/3/2021 |
ESLOY EssilorLuxottica Société anonyme | $130.68
+3.6% | 10/29/2021 | Upgraded by | Bryan, Garnier & Co | Analyst Cedric Rossi | Neutral -> Buy | | High | View details for Bryan, Garnier & Co rating of EssilorLuxottica Société anonyme (OTCMKTS:ESLOY) on 10/29/2021 |
BNTX BioNTech | $117.25
+4.8% | 10/5/2021 | Target Set by | Bryan, Garnier & Co | Analyst Olga Smolentseva | | $359.00 | Low | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 10/5/2021 |
CODYY Compagnie de Saint-Gobain | $18.36
+3.3% | 10/1/2021 | Upgraded by | Bryan, Garnier & Co | Analyst Eric Lemaire | Neutral -> Buy | $80.00 | Low | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 10/1/2021 |
BNTX BioNTech | $117.25
+4.8% | 9/24/2021 | Target Set by | Bryan, Garnier & Co | Analyst Olga Smolentseva | | $451.00 | High | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 9/24/2021 |
Texas embraces new currency (Ad) Rural Texas Town Ramps Up Global Currency War
A small town has joined a radical $1.9 trillion attack on the global banking system... backed up by Elon Musk and the White House. Read about it here. |
VALN Valneva | $4.71
+7.8% | 9/13/2021 | Downgraded by | Bryan, Garnier & Co | Analyst Jean-Jacques Le Fur | Buy -> Neutral | | High | View details for Bryan, Garnier & Co rating of Valneva (NASDAQ:VALN) on 9/13/2021 |
ERFSF Eurofins Scientific | $49.19
-0.6% | 8/25/2021 | Downgraded by | Bryan, Garnier & Co | Analyst Bruno De | Strong-Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Eurofins Scientific (OTCMKTS:ERFSF) on 8/25/2021 |
BNTX BioNTech | $117.25
+4.8% | 8/11/2021 | Upgraded by | Bryan, Garnier & Co | Analyst Olga Smolentseva | Neutral -> Buy | | High | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 8/11/2021 |
BOUYF Bouygues | $31.85
+0.5% | 7/27/2021 | Upgraded by | Bryan, Garnier & Co | Analyst Thomas Coudry | Neutral -> Buy | $37.20 | Low | View details for Bryan, Garnier & Co rating of Bouygues (OTCMKTS:BOUYF) on 7/27/2021 |
ERFSF Eurofins Scientific | $49.19
-0.6% | 7/9/2021 | Downgraded by | Bryan, Garnier & Co | Analyst Bruno De | Buy -> Neutral | | High | View details for Bryan, Garnier & Co rating of Eurofins Scientific (OTCMKTS:ERFSF) on 7/9/2021 |
LGRDY Legrand | $20.79
+4.0% | 6/29/2021 | Downgraded by | Bryan, Garnier & Co | Analyst Eric Lemaire | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Legrand (OTCMKTS:LGRDY) on 6/29/2021 |
CODYY Compagnie de Saint-Gobain | $18.36
+3.3% | 6/9/2021 | Downgraded by | Bryan, Garnier & Co | Analyst Eric Lemaire | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 6/9/2021 |
MOR MorphoSys | $18.96
| 6/3/2021 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Medium | View details for Bryan, Garnier & Co rating of MorphoSys (NASDAQ:MOR) on 6/3/2021 |
BNTX BioNTech | $117.25
+4.8% | 5/17/2021 | Reiterated by | Bryan, Garnier & Co | - | Buy -> Neutral | $135.00 -> $206.00 | N/A | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/17/2021 |
BAYRY Bayer Aktiengesellschaft | $5.60
+3.1% | 5/13/2021 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 5/13/2021 |
BNTX BioNTech | $117.25
+4.8% | 5/11/2021 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | $135.00 -> $206.00 | Low | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/11/2021 |
BUD Anheuser-Busch InBev SA/NV | $48.30
+0.6% | 5/6/2021 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Buy | | Medium | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 5/6/2021 |
DBVT DBV Technologies | $4.52
+1.1% | 5/3/2021 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Buy | | Low | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 5/3/2021 |
MTLS Materialise | $7.87
+3.6% | 3/10/2021 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | $43.00 | High | View details for Bryan, Garnier & Co rating of Materialise (NASDAQ:MTLS) on 3/10/2021 |
ECIFY Electricité de France | $2.55
| 2/24/2021 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | Low | View details for Bryan, Garnier & Co rating of Electricité de France (OTCMKTS:ECIFY) on 2/24/2021 |
GNFT Genfit | $3.66
+5.5% | 2/12/2021 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Low | View details for Bryan, Garnier & Co rating of Genfit (NASDAQ:GNFT) on 2/12/2021 |
DASTY Dassault Systèmes | $36.80
+2.8% | 2/5/2021 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Buy | | Low | View details for Bryan, Garnier & Co rating of Dassault Systèmes (OTCMKTS:DASTY) on 2/5/2021 |
SDXAY Sodexo | $14.58
+2.1% | 2/3/2021 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Low | View details for Bryan, Garnier & Co rating of Sodexo (OTCMKTS:SDXAY) on 2/3/2021 |
VCISY Vinci | $26.95
+2.3% | 1/14/2021 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Neutral | | Medium | View details for Bryan, Garnier & Co rating of Vinci (OTCMKTS:VCISY) on 1/14/2021 |
IFNNY Infineon Technologies | $36.07
+2.9% | 1/14/2021 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Infineon Technologies (OTCMKTS:IFNNY) on 1/14/2021 |
STM STMicroelectronics | $25.77
+1.6% | 1/8/2021 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | High | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 1/8/2021 |
CODYY Compagnie de Saint-Gobain | $18.36
+3.3% | 1/7/2021 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | N/A | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 1/7/2021 |
GLPG Galapagos | $23.83
+0.3% | 12/17/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Sell | | High | View details for Bryan, Garnier & Co rating of Galapagos (NASDAQ:GLPG) on 12/17/2020 |
SCRYY Scor | $2.57
+2.4% | 12/17/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy | | Low | View details for Bryan, Garnier & Co rating of Scor (OTCMKTS:SCRYY) on 12/17/2020 |
ITMPF ITM Power | $0.44
-0.5% | 12/11/2020 | Initiated by | Bryan, Garnier & Co | - | Buy | | Low | View details for Bryan, Garnier & Co rating of ITM Power (OTCMKTS:ITMPF) on 12/11/2020 |
STM STMicroelectronics | $25.77
+1.6% | 12/10/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 12/10/2020 |
BAYRY Bayer Aktiengesellschaft | $5.60
+3.1% | 10/1/2020 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | High | View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 10/1/2020 |
GMAB Genmab A/S | $21.80
+4.8% | 9/23/2020 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | High | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 9/23/2020 |
IHG InterContinental Hotels Group | $129.83
+2.4% | 9/21/2020 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | Low | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (NYSE:IHG) on 9/21/2020 |
IPHA Innate Pharma | $1.77
+4.4% | 9/9/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Innate Pharma (NASDAQ:IPHA) on 9/9/2020 |
DBVT DBV Technologies | $4.52
+1.1% | 8/4/2020 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | High | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 8/4/2020 |
BUD Anheuser-Busch InBev SA/NV | $48.30
+0.6% | 7/15/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Sell | | Low | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 7/15/2020 |
TAP Molson Coors Beverage | $55.72
+0.9% | 7/15/2020 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Buy | $49.00 | Low | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 7/15/2020 |
DEO Diageo | $119.80
+0.9% | 7/8/2020 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Low | View details for Bryan, Garnier & Co rating of Diageo (NYSE:DEO) on 7/8/2020 |
BNTX BioNTech | $117.25
+4.8% | 7/2/2020 | Target Raised by | Bryan, Garnier & Co | - | | $50.00 -> $62.00 | High | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 7/2/2020 |
STM STMicroelectronics | $25.77
+1.6% | 6/29/2020 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Low | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 6/29/2020 |
GMAB Genmab A/S | $21.80
+4.8% | 6/3/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 6/3/2020 |
AZN AstraZeneca | £110.50
0.0% | 6/2/2020 | Target Raised by | Bryan, Garnier & Co | - | Buy | GBX 8,780 -> GBX 9,100 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 6/2/2020 |
CGC Canopy Growth | $2.23
+2.3% | 6/1/2020 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | High | View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 6/1/2020 |
GNFT Genfit | $3.66
+5.5% | 5/13/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Medium | View details for Bryan, Garnier & Co rating of Genfit (NASDAQ:GNFT) on 5/13/2020 |
AZN AstraZeneca | £110.50
0.0% | 5/11/2020 | Target Raised by | Bryan, Garnier & Co | - | Buy | GBX 8,550 -> GBX 8,780 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 5/11/2020 |
DBVT DBV Technologies | $4.52
+1.1% | 3/18/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | High | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 3/18/2020 |
SGE The Sage Group | GBX 1,328
+0.5% | 3/2/2020 | Target Lowered by | Bryan, Garnier & Co | - | Neutral | GBX 690 -> GBX 680 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 3/2/2020 |
BUD Anheuser-Busch InBev SA/NV | $48.30
+0.6% | 2/28/2020 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | High | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 2/28/2020 |
ACB Aurora Cannabis | $3.90
+1.3% | 2/27/2020 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | Low | View details for Bryan, Garnier & Co rating of Aurora Cannabis (NASDAQ:ACB) on 2/27/2020 |
GSK GSK | GBX 1,359.50
+0.1% | 2/6/2020 | Target Lowered by | Bryan, Garnier & Co | - | Neutral | GBX 1,800 -> GBX 1,773 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 2/6/2020 |
SAP SAP | €256.75
+0.3% | 1/28/2020 | Target Set by | Bryan, Garnier & Co | - | Buy | €153.00 | N/A | View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 1/28/2020 |
ASML ASML | $763.00
+0.9% | 1/14/2020 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Medium | View details for Bryan, Garnier & Co rating of ASML (NASDAQ:ASML) on 1/14/2020 |
BRBY Burberry Group | GBX 1,043
+2.7% | 1/10/2020 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 1,780 -> GBX 1,860 | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/10/2020 |
AZN AstraZeneca | £110.50
0.0% | 12/19/2019 | Reiterated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/19/2019 |
Did You See Trump’s Manhattan Project Bombshell? (Ad) This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House.
Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)...
Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.  Click here and see for yourself. |
GSK GSK | GBX 1,359.50
+0.1% | 12/19/2019 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 1,660 -> GBX 1,747 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 12/19/2019 |
AZN AstraZeneca | £110.50
0.0% | 11/25/2019 | Upgraded by | Bryan, Garnier & Co | - | Buy | GBX 7,700 -> GBX 7,950 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/25/2019 |
CABGY Carlsberg A/S | $20.32
+5.0% | 8/12/2019 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Low | View details for Bryan, Garnier & Co rating of Carlsberg A/S (OTCMKTS:CABGY) on 8/12/2019 |
TAP Molson Coors Beverage | $55.72
+0.9% | 8/1/2019 | Reiterated by | Bryan, Garnier & Co | - | Neutral -> Sell | $51.00 | High | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 8/1/2019 |
CGC Canopy Growth | $2.23
+2.3% | 7/5/2019 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 7/5/2019 |
WEED Canopy Growth | C$3.19
-0.6% | 7/4/2019 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | C$85.00 -> C$60.00 | N/A | View details for Bryan, Garnier & Co rating of Canopy Growth (TSE:WEED) on 7/4/2019 |
AZN AstraZeneca | £110.50
0.0% | 7/3/2019 | Reiterated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 7/3/2019 |
BURBY Burberry Group | $12.57
+4.0% | 5/20/2019 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Burberry Group (OTCMKTS:BURBY) on 5/20/2019 |
BRBY Burberry Group | GBX 1,043
+2.7% | 5/20/2019 | Upgraded by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 5/20/2019 |
ADDYY adidas | $132.22
+6.6% | 5/6/2019 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | High | View details for Bryan, Garnier & Co rating of adidas (OTCMKTS:ADDYY) on 5/6/2019 |
GSK GSK | GBX 1,359.50
+0.1% | 5/2/2019 | Target Lowered by | Bryan, Garnier & Co | - | Neutral | GBX 1,710 -> GBX 1,660 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 5/2/2019 |
PDRDY Pernod Ricard | $47.12
| 3/29/2019 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Pernod Ricard (OTCMKTS:PDRDY) on 3/29/2019 |
AZN AstraZeneca | £110.50
0.0% | 3/29/2019 | Reiterated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 3/29/2019 |
BAYRY Bayer Aktiengesellschaft | $5.60
+3.1% | 3/28/2019 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | Low | View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 3/28/2019 |
HESAY Hermès International Société en commandite par actions | $267.83
+4.1% | 3/25/2019 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | Low | View details for Bryan, Garnier & Co rating of Hermès International Société en commandite par actions (OTCMKTS:HESAY) on 3/25/2019 |
AZN AstraZeneca | £110.50
0.0% | 2/22/2019 | Downgraded by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 2/22/2019 |
IHG InterContinental Hotels Group | £104.70
+0.8% | 2/19/2019 | Reiterated by | Bryan, Garnier & Co | - | Sell | | N/A | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/19/2019 |
SGE The Sage Group | GBX 1,328
+0.5% | 1/17/2019 | Target Lowered by | Bryan, Garnier & Co | - | Buy | GBX 850 -> GBX 630 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/17/2019 |
AZN AstraZeneca | £110.50
0.0% | 11/8/2018 | Downgraded by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/8/2018 |
LVMUY LVMH Moët Hennessy - Louis Vuitton, Société Européenne | $146.35
+3.0% | 4/24/2018 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Medium | View details for Bryan, Garnier & Co rating of LVMH Moët Hennessy - Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) on 4/24/2018 |
SOW Software Aktiengesellschaft | €36.68
| 4/17/2018 | Target Set by | Bryan, Garnier & Co | - | Buy | €49.00 | N/A | View details for Bryan, Garnier & Co rating of Software Aktiengesellschaft (ETR:SOW) on 4/17/2018 |
MOR MorphoSys | €67.25
| 4/9/2018 | Target Set by | Bryan, Garnier & Co | - | Buy | €91.00 | N/A | View details for Bryan, Garnier & Co rating of MorphoSys (ETR:MOR) on 4/9/2018 |
SAP SAP | €256.75
+0.3% | 4/6/2018 | Target Set by | Bryan, Garnier & Co | - | Buy | €112.00 | N/A | View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 4/6/2018 |
MOR MorphoSys | €67.25
| 3/14/2018 | Target Set by | Bryan, Garnier & Co | - | Buy | €91.20 | N/A | View details for Bryan, Garnier & Co rating of MorphoSys (ETR:MOR) on 3/14/2018 |
IGY innogy SE (IGY.F) | €43.60
| 3/12/2018 | Target Set by | Bryan, Garnier & Co | - | Neutral | €31.00 | N/A | View details for Bryan, Garnier & Co rating of innogy SE (IGY.F) (ETR:IGY) on 3/12/2018 |
IHG InterContinental Hotels Group | £104.70
+0.8% | 2/20/2018 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 4,100 | N/A | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/20/2018 |
DGE Diageo | GBX 2,424.50
-0.2% | 1/25/2018 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 2,320 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/25/2018 |
SGE The Sage Group | GBX 1,328
+0.5% | 1/25/2018 | Target Lowered by | Bryan, Garnier & Co | - | Buy | GBX 860 -> GBX 850 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/25/2018 |
AZN AstraZeneca | £110.50
0.0% | 12/15/2017 | Reiterated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/15/2017 |
SGE The Sage Group | GBX 1,328
+0.5% | 11/23/2017 | Target Raised by | Bryan, Garnier & Co | - | Buy | GBX 830 -> GBX 860 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/23/2017 |
BRBY Burberry Group | GBX 1,043
+2.7% | 11/10/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 11/10/2017 |
ULVR Unilever | GBX 4,614
0.0% | 10/20/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 4,350 | N/A | View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 10/20/2017 |
MBGAF Mercedes-Benz Group | $58.64
+3.7% | 9/25/2017 | Initiated by | Bryan, Garnier & Co | - | Buy | | Low | View details for Bryan, Garnier & Co rating of Mercedes-Benz Group (OTCMKTS:MBGAF) on 9/25/2017 |
SGPYY The Sage Group | $65.30
+1.7% | 9/24/2017 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (OTCMKTS:SGPYY) on 9/24/2017 |
SGPYY The Sage Group | $65.30
+1.7% | 9/22/2017 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | Low | View details for Bryan, Garnier & Co rating of The Sage Group (OTCMKTS:SGPYY) on 9/22/2017 |
SGE The Sage Group | GBX 1,328
+0.5% | 9/22/2017 | Upgraded by | Bryan, Garnier & Co | - | Buy | GBX 720 -> GBX 830 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 9/22/2017 |
GSK GSK | GBX 1,359.50
+0.1% | 9/19/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,710 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 9/19/2017 |
TSCO Tesco | GBX 367.20
-0.1% | 9/12/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 170 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 9/12/2017 |
AZN AstraZeneca | £110.50
0.0% | 9/11/2017 | Upgraded by | Bryan, Garnier & Co | - | Buy | GBX 4,700 -> GBX 5,380 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 9/11/2017 |
BRBY Burberry Group | GBX 1,043
+2.7% | 9/11/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 9/11/2017 |
CPG Compass Group | GBX 2,728
+1.0% | 8/29/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,550 | N/A | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 8/29/2017 |
ULVR Unilever | GBX 4,614
0.0% | 8/25/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 4,300 | N/A | View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 8/25/2017 |
IHG InterContinental Hotels Group | £104.70
+0.8% | 8/24/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 3,520 | N/A | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 8/24/2017 |
DGE Diageo | GBX 2,424.50
-0.2% | 8/23/2017 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 2,210 -> GBX 2,320 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 8/23/2017 |
GSK GSK | GBX 1,359.50
+0.1% | 7/26/2017 | Target Raised by | Bryan, Garnier & Co | - | Buy | GBX 1,750 -> GBX 1,790 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/26/2017 |
GSK GSK | GBX 1,359.50
+0.1% | 7/20/2017 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 1,750 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/20/2017 |
TSCO Tesco | GBX 367.20
-0.1% | 6/20/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 170 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 6/20/2017 |
TSCO Tesco | GBX 367.20
-0.1% | 6/14/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 170 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 6/14/2017 |
GSK GSK | GBX 1,359.50
+0.1% | 5/31/2017 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 1,750 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 5/31/2017 |
BRBY Burberry Group | GBX 1,043
+2.7% | 4/20/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 4/20/2017 |
Did You See Trump’s Manhattan Project Bombshell? (Ad) This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House.
Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)...
Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. Click here and see for yourself. |
BRBY Burberry Group | GBX 1,043
+2.7% | 4/13/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 1,350 | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 4/13/2017 |
TSCO Tesco | GBX 367.20
-0.1% | 4/13/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 170 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 4/13/2017 |
TSCO Tesco | GBX 367.20
-0.1% | 3/23/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 170 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 3/23/2017 |
DGE Diageo | GBX 2,424.50
-0.2% | 3/17/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 2,210 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 3/17/2017 |
SGE The Sage Group | GBX 1,328
+0.5% | 3/6/2017 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 640 -> GBX 660 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 3/6/2017 |
AZN AstraZeneca | £110.50
0.0% | 2/28/2017 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,400 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 2/28/2017 |
IHG InterContinental Hotels Group | £104.70
+0.8% | 2/21/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 2,950 | N/A | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/21/2017 |
CPG Compass Group | GBX 2,728
+1.0% | 2/3/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,475 | N/A | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 2/3/2017 |
SGE The Sage Group | GBX 1,328
+0.5% | 2/1/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 640 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 2/1/2017 |
TSCO Tesco | GBX 367.20
-0.1% | 1/30/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 170 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/30/2017 |
ULVR Unilever | GBX 4,614
0.0% | 1/27/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 3,570 | N/A | View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 1/27/2017 |
DGE Diageo | GBX 2,424.50
-0.2% | 1/26/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 2,150 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/26/2017 |
SGE The Sage Group | GBX 1,328
+0.5% | 1/26/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 650 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/26/2017 |
BRBY Burberry Group | GBX 1,043
+2.7% | 1/18/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 1,350 | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/18/2017 |
DGE Diageo | GBX 2,424.50
-0.2% | 1/16/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 2,150 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/16/2017 |
MRK Merck & Co., Inc. | $96.18
-1.8% | 1/13/2017 | Initiated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of Merck & Co., Inc. (NYSE:MRK) on 1/13/2017 |
BRBY Burberry Group | GBX 1,043
+2.7% | 1/10/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 1,350 | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/10/2017 |
CPG Compass Group | GBX 2,728
+1.0% | 1/9/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,430 | N/A | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 1/9/2017 |
AZN AstraZeneca | £110.50
0.0% | 1/9/2017 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,250 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 1/9/2017 |
GSK GSK | GBX 1,359.50
+0.1% | 1/9/2017 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 1,850 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 1/9/2017 |
PNN Pennon Group | GBX 532
-0.9% | 1/6/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 830 | N/A | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 1/6/2017 |
BRBY Burberry Group | GBX 1,043
+2.7% | 1/4/2017 | Downgraded by | Bryan, Garnier & Co | - | Sell | GBX 1,350 | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/4/2017 |
DGE Diageo | GBX 2,424.50
-0.2% | 1/4/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 2,150 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/4/2017 |
ULVR Unilever | GBX 4,614
0.0% | 1/4/2017 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 3,990 | N/A | View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 1/4/2017 |
TSCO Tesco | GBX 367.20
-0.1% | 1/4/2017 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 170 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/4/2017 |
AZN AstraZeneca | £110.50
0.0% | 12/12/2016 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,100 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/12/2016 |
SGE The Sage Group | GBX 1,328
+0.5% | 11/30/2016 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 690 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/30/2016 |
CMPGY Compass Group | $33.39
+2.6% | 11/25/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Compass Group (OTCMKTS:CMPGY) on 11/25/2016 |
DGE Diageo | GBX 2,424.50
-0.2% | 11/23/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 11/23/2016 |
AZN AstraZeneca | £110.50
0.0% | 11/22/2016 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,100 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/22/2016 |
CPG Compass Group | GBX 2,728
+1.0% | 11/22/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,450 | N/A | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 11/22/2016 |
AZN AstraZeneca | £110.50
0.0% | 10/26/2016 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,220 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/26/2016 |
BRBY Burberry Group | GBX 1,043
+2.7% | 10/25/2016 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 1,260 -> GBX 1,350 | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 10/25/2016 |
BRBY Burberry Group | GBX 1,043
+2.7% | 10/19/2016 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 1,200 -> GBX 1,250 | N/A | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 10/19/2016 |
AZN AstraZeneca | £110.50
0.0% | 10/17/2016 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,220 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/17/2016 |
GSK GSK | GBX 1,359.50
+0.1% | 10/17/2016 | Reiterated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 10/17/2016 |
SGE The Sage Group | GBX 1,328
+0.5% | 10/12/2016 | Target Raised by | Bryan, Garnier & Co | - | Sell | GBX 600 -> GBX 690 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 10/12/2016 |
TSCO Tesco | GBX 367.20
-0.1% | 10/5/2016 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 166 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 10/5/2016 |
AZN AstraZeneca | £110.50
0.0% | 10/4/2016 | Target Lowered by | Bryan, Garnier & Co | - | Buy | GBX 5,400 -> GBX 5,220 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/4/2016 |
SGE The Sage Group | GBX 1,328
+0.5% | 9/30/2016 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 600 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 9/30/2016 |
IHG InterContinental Hotels Group | £104.70
+0.8% | 9/27/2016 | Downgraded by | Bryan, Garnier & Co | - | Sell | GBX 2,650 -> GBX 2,950 | N/A | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 9/27/2016 |
AZN AstraZeneca | £110.50
0.0% | 7/28/2016 | Reiterated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 7/28/2016 |
GSK GSK | GBX 1,359.50
+0.1% | 7/28/2016 | Reiterated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/28/2016 |
TAP Molson Coors Beverage | $55.72
+0.9% | 7/8/2016 | Upgraded by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 7/8/2016 |
SGE The Sage Group | GBX 1,328
+0.5% | 5/5/2016 | Reiterated by | Bryan, Garnier & Co | - | Sell | GBX 550 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 5/5/2016 |
TSCO Tesco | GBX 367.20
-0.1% | 4/4/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 166 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 4/4/2016 |
CPG Compass Group | GBX 2,728
+1.0% | 4/4/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,200 | N/A | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 4/4/2016 |
AZN AstraZeneca | £110.50
0.0% | 3/10/2016 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,520 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 3/10/2016 |
PNN Pennon Group | GBX 532
-0.9% | 2/11/2016 | Downgraded by | Bryan, Garnier & Co | - | Sell | GBX 825 | N/A | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 2/11/2016 |
PNN Pennon Group | GBX 532
-0.9% | 2/4/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 800 | N/A | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 2/4/2016 |
Did You See Trump’s Manhattan Project Bombshell? (Ad) This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House.
Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)...
Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. Click here and see for yourself. |
SGE The Sage Group | GBX 1,328
+0.5% | 1/28/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 570 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/28/2016 |
GSK GSK | $33.76
+1.0% | 1/27/2016 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | N/A | View details for Bryan, Garnier & Co rating of GSK (NYSE:GSK) on 1/27/2016 |
GSK GSK | GBX 1,359.50
+0.1% | 1/27/2016 | Upgraded by | Bryan, Garnier & Co | - | Buy | GBX 1,635 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 1/27/2016 |
ASML ASML | $763.00
+0.9% | 1/21/2016 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | N/A | View details for Bryan, Garnier & Co rating of ASML (NASDAQ:ASML) on 1/21/2016 |
TSCO Tesco | GBX 367.20
-0.1% | 1/14/2016 | Initiated by | Bryan, Garnier & Co | - | Neutral | GBX 166 | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/14/2016 |
PNN Pennon Group | GBX 532
-0.9% | 1/8/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 800 | N/A | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 1/8/2016 |
IHG InterContinental Hotels Group | £104.70
+0.8% | 1/7/2016 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 2,650 | N/A | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 1/7/2016 |
CPG Compass Group | GBX 2,728
+1.0% | 1/5/2016 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 1,150 -> GBX 1,200 | N/A | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 1/5/2016 |
SGE The Sage Group | GBX 1,328
+0.5% | 12/18/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 540 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 12/18/2015 |
GLPG Galapagos | $23.83
+0.3% | 12/17/2015 | Target Raised by | Bryan, Garnier & Co | - | Buy | $52.00 -> $64.00 | N/A | View details for Bryan, Garnier & Co rating of Galapagos (NASDAQ:GLPG) on 12/17/2015 |
DGE Diageo | GBX 2,424.50
-0.2% | 12/3/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,870 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 12/3/2015 |
TSCO Tesco | GBX 367.20
-0.1% | 12/1/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 12/1/2015 |
PNN Pennon Group | GBX 532
-0.9% | 11/27/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 800 | N/A | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 11/27/2015 |
SGE The Sage Group | GBX 1,328
+0.5% | 11/27/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 540 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/27/2015 |
TSCDY Tesco | $13.65
+2.1% | 11/25/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Tesco (OTCMKTS:TSCDY) on 11/25/2015 |
TSCO Tesco | GBX 367.20
-0.1% | 11/25/2015 | Initiated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 11/25/2015 |
CPG Compass Group | GBX 2,728
+1.0% | 11/24/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,150 | N/A | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 11/24/2015 |
TAP Molson Coors Beverage | $55.72
+0.9% | 11/17/2015 | Initiated by | Bryan, Garnier & Co | - | Buy | $101.00 | N/A | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 11/17/2015 |
SGE The Sage Group | GBX 1,328
+0.5% | 11/13/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 540 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/13/2015 |
AZN AstraZeneca | £110.50
0.0% | 11/12/2015 | Target Raised by | Bryan, Garnier & Co | - | Buy | GBX 5,100 -> GBX 5,150 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/12/2015 |
SNY Sanofi | $51.69
+1.9% | 11/9/2015 | Reiterated by | Bryan, Garnier & Co | - | Buy -> Neutral | | N/A | View details for Bryan, Garnier & Co rating of Sanofi (NASDAQ:SNY) on 11/9/2015 |
PNN Pennon Group | GBX 532
-0.9% | 10/26/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 800 | N/A | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 10/26/2015 |
AZN AstraZeneca | £110.50
0.0% | 10/23/2015 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,100 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/23/2015 |
UBSFY Ubisoft Entertainment | $2.29
-3.4% | 10/15/2015 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | N/A | View details for Bryan, Garnier & Co rating of Ubisoft Entertainment (OTCMKTS:UBSFY) on 10/15/2015 |
AZN AstraZeneca | £110.50
0.0% | 10/12/2015 | Reiterated by | Bryan, Garnier & Co | - | Buy | GBX 5,400 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/12/2015 |
SGE The Sage Group | GBX 1,328
+0.5% | 10/6/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 520 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 10/6/2015 |
IHG InterContinental Hotels Group | £104.70
+0.8% | 10/5/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 10/5/2015 |
DGE Diageo | GBX 2,424.50
-0.2% | 10/1/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,870 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 10/1/2015 |
DGE Diageo | GBX 2,424.50
-0.2% | 9/23/2015 | Target Lowered by | Bryan, Garnier & Co | - | Neutral | GBX 1,920 -> GBX 1,870 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 9/23/2015 |
AZN AstraZeneca | $67.96
+2.0% | 9/18/2015 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (NASDAQ:AZN) on 9/18/2015 |
AZN AstraZeneca | £110.50
0.0% | 9/10/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 4,830 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 9/10/2015 |
GSK GSK | GBX 1,359.50
+0.1% | 9/9/2015 | Target Lowered by | Bryan, Garnier & Co | - | Neutral | GBX 1,480 -> GBX 1,470 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 9/9/2015 |
PNN Pennon Group | GBX 532
-0.9% | 8/25/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 835 | N/A | View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 8/25/2015 |
GSK GSK | GBX 1,359.50
+0.1% | 8/21/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,480 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 8/21/2015 |
AZN AstraZeneca | £110.50
0.0% | 8/21/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 4,830 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 8/21/2015 |
DGE Diageo | GBX 2,424.50
-0.2% | 7/29/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,920 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 7/29/2015 |
SGE The Sage Group | GBX 1,328
+0.5% | 7/21/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 520 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 7/21/2015 |
VCISY Vinci | $26.95
+2.3% | 7/17/2015 | Initiated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of Vinci (OTCMKTS:VCISY) on 7/17/2015 |
DANOY Danone | $13.60
+1.9% | 7/8/2015 | Initiated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of Danone (OTCMKTS:DANOY) on 7/8/2015 |
DGE Diageo | GBX 2,424.50
-0.2% | 7/2/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,920 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 7/2/2015 |
DASTY Dassault Systèmes | $36.80
+2.8% | 6/30/2015 | Downgraded by | Bryan, Garnier & Co | - | Neutral -> Sell | | N/A | View details for Bryan, Garnier & Co rating of Dassault Systèmes (OTCMKTS:DASTY) on 6/30/2015 |
NVS Novartis | $99.69
+2.2% | 6/22/2015 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | N/A | View details for Bryan, Garnier & Co rating of Novartis (NYSE:NVS) on 6/22/2015 |
IFNNY Infineon Technologies | $36.07
+2.9% | 6/11/2015 | Initiated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of Infineon Technologies (OTCMKTS:IFNNY) on 6/11/2015 |
DLGNF Dialog Semiconductor | $80.41
| 6/11/2015 | Initiated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of Dialog Semiconductor (OTCMKTS:DLGNF) on 6/11/2015 |
GSK GSK | GBX 1,359.50
+0.1% | 6/2/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,580 | N/A | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 6/2/2015 |
IHG InterContinental Hotels Group | £104.70
+0.8% | 5/21/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 2,650 | N/A | View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 5/21/2015 |
UBSFY Ubisoft Entertainment | $2.29
-3.4% | 5/13/2015 | Downgraded by | Bryan, Garnier & Co | - | Buy -> Neutral | | N/A | View details for Bryan, Garnier & Co rating of Ubisoft Entertainment (OTCMKTS:UBSFY) on 5/13/2015 |
DGE Diageo | GBX 2,424.50
-0.2% | 5/6/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 1,950 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 5/6/2015 |
HEINY Heineken | $34.54
+1.4% | 5/5/2015 | Initiated by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of Heineken (OTCMKTS:HEINY) on 5/5/2015 |
CABGY Carlsberg A/S | $20.32
+5.0% | 5/5/2015 | Initiated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Carlsberg A/S (OTCMKTS:CABGY) on 5/5/2015 |
BUD Anheuser-Busch InBev SA/NV | $48.30
+0.6% | 5/5/2015 | Initiated by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 5/5/2015 |
AEG Aegon | $6.48
+1.6% | 4/15/2015 | Upgraded by | Bryan, Garnier & Co | - | Neutral -> Buy | | N/A | View details for Bryan, Garnier & Co rating of Aegon (NYSE:AEG) on 4/15/2015 |
RANJY Randstad | $21.66
+4.3% | 4/14/2015 | Upgraded by | Bryan, Garnier & Co | - | Sell -> Buy | | N/A | View details for Bryan, Garnier & Co rating of Randstad (OTCMKTS:RANJY) on 4/14/2015 |
AZN AstraZeneca | £110.50
0.0% | 4/10/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 4,740 | N/A | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 4/10/2015 |
DGE Diageo | GBX 2,424.50
-0.2% | 4/1/2015 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 1,880 -> GBX 2,000 | N/A | View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 4/1/2015 |
CPG Compass Group | GBX 2,728
+1.0% | 3/30/2015 | Target Raised by | Bryan, Garnier & Co | - | Neutral | GBX 1,070 -> GBX 1,220 | N/A | View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 3/30/2015 |
NVO Novo Nordisk A/S | $80.95
+2.9% | 3/26/2015 | Downgraded by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 3/26/2015 |
PPRUY Kering | $25.98
+4.0% | 2/18/2015 | Downgraded by | Bryan, Garnier & Co | - | Neutral | | N/A | View details for Bryan, Garnier & Co rating of Kering (OTCMKTS:PPRUY) on 2/18/2015 |
LVMUY LVMH Moët Hennessy - Louis Vuitton, Société Européenne | $146.35
+3.0% | 2/4/2015 | Upgraded by | Bryan, Garnier & Co | - | Buy | | N/A | View details for Bryan, Garnier & Co rating of LVMH Moët Hennessy - Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) on 2/4/2015 |
SGE The Sage Group | GBX 1,328
+0.5% | 1/29/2015 | Reiterated by | Bryan, Garnier & Co | - | Neutral | GBX 450 | N/A | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/29/2015 |
